Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer’s disease

Eitemau Tebyg

• Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer’s disease
  gan: Reddy, P. Hemachandra, et al.
  Cyhoeddwyd: (2017)
• Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer’s Disease
  gan: Reddy, P. Hemachandra, et al.
  Cyhoeddwyd: (2018)
• Mitochondria-targeted small peptide, SS31 ameliorates diabetes induced mitochondrial dynamics in male TallyHO/JngJ mice
  gan: Bhatti, Jasvinder Singh, et al.
  Cyhoeddwyd: (2020)
• Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
  gan: Calkins, Marcus J., et al.
  Cyhoeddwyd: (2012)
• Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease
  gan: Yin, Xiangling, et al.
  Cyhoeddwyd: (2016)